These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 18726569

  • 1. Analysis of Abeta interactions using ProteinChip technology.
    Giannakis E, Hung LW, Camacaro KP, Smith DP, Barnham KJ, Wade JD.
    Methods Mol Biol; 2008; 494():71-86. PubMed ID: 18726569
    [Abstract] [Full Text] [Related]

  • 2. Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease.
    Barghorn S, Nimmrich V, Striebinger A, Krantz C, Keller P, Janson B, Bahr M, Schmidt M, Bitner RS, Harlan J, Barlow E, Ebert U, Hillen H.
    J Neurochem; 2005 Nov; 95(3):834-47. PubMed ID: 16135089
    [Abstract] [Full Text] [Related]

  • 3. Amyloidogenic processing of amyloid precursor protein: evidence of a pivotal role of glutaminyl cyclase in generation of pyroglutamate-modified amyloid-beta.
    Cynis H, Scheel E, Saido TC, Schilling S, Demuth HU.
    Biochemistry; 2008 Jul 15; 47(28):7405-13. PubMed ID: 18570439
    [Abstract] [Full Text] [Related]

  • 4. Lipid-induced conformational transition of the amyloid core fragment Abeta(28-35) and its A30G and A30I mutants.
    Nagarajan S, Ramalingam K, Neelakanta Reddy P, Cereghetti DM, Padma Malar EJ, Rajadas J.
    FEBS J; 2008 May 15; 275(10):2415-27. PubMed ID: 18422968
    [Abstract] [Full Text] [Related]

  • 5. Antiparallel beta-sheet: a signature structure of the oligomeric amyloid beta-peptide.
    Cerf E, Sarroukh R, Tamamizu-Kato S, Breydo L, Derclaye S, Dufrêne YF, Narayanaswami V, Goormaghtigh E, Ruysschaert JM, Raussens V.
    Biochem J; 2009 Jul 15; 421(3):415-23. PubMed ID: 19435461
    [Abstract] [Full Text] [Related]

  • 6. Why is the amyloid beta peptide of Alzheimer's disease neurotoxic?
    Rauk A.
    Dalton Trans; 2008 Mar 14; (10):1273-82. PubMed ID: 18305836
    [Abstract] [Full Text] [Related]

  • 7. Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide.
    Tõugu V, Karafin A, Palumaa P.
    J Neurochem; 2008 Mar 14; 104(5):1249-59. PubMed ID: 18289347
    [Abstract] [Full Text] [Related]

  • 8. Mechanism of copper(II) inhibiting Alzheimer's amyloid beta-peptide from aggregation: a molecular dynamics investigation.
    Jiao Y, Yang P.
    J Phys Chem B; 2007 Jul 05; 111(26):7646-55. PubMed ID: 17564430
    [Abstract] [Full Text] [Related]

  • 9. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
    Meli G, Visintin M, Cannistraci I, Cattaneo A.
    J Mol Biol; 2009 Apr 03; 387(3):584-606. PubMed ID: 19361429
    [Abstract] [Full Text] [Related]

  • 10. Fluorescence anisotropy: a method for early detection of Alzheimer beta-peptide (Abeta) aggregation.
    Allsop D, Swanson L, Moore S, Davies Y, York A, El-Agnaf OM, Soutar I.
    Biochem Biophys Res Commun; 2001 Jul 06; 285(1):58-63. PubMed ID: 11437372
    [Abstract] [Full Text] [Related]

  • 11. High resolution scanning tunnelling microscopy of the beta-amyloid protein (Abeta1-40) of Alzheimer's disease suggests a novel mechanism of oligomer assembly.
    Losic D, Martin LL, Mechler A, Aguilar MI, Small DH.
    J Struct Biol; 2006 Jul 06; 155(1):104-10. PubMed ID: 16650774
    [Abstract] [Full Text] [Related]

  • 12. ProteinChip array-based amyloid beta assays.
    Bradbury LE, LeBlanc JF, McCarthy DB.
    Methods Mol Biol; 2004 Jul 06; 264():245-57. PubMed ID: 15020795
    [Abstract] [Full Text] [Related]

  • 13. The role of cell-derived oligomers of Abeta in Alzheimer's disease and avenues for therapeutic intervention.
    Walsh DM, Klyubin I, Shankar GM, Townsend M, Fadeeva JV, Betts V, Podlisny MB, Cleary JP, Ashe KH, Rowan MJ, Selkoe DJ.
    Biochem Soc Trans; 2005 Nov 06; 33(Pt 5):1087-90. PubMed ID: 16246051
    [Abstract] [Full Text] [Related]

  • 14. Identification of novel APP/Abeta isoforms in human cerebrospinal fluid.
    Portelius E, Brinkmalm G, Tran AJ, Zetterberg H, Westman-Brinkmalm A, Blennow K.
    Neurodegener Dis; 2009 Nov 06; 6(3):87-94. PubMed ID: 19229112
    [Abstract] [Full Text] [Related]

  • 15. Ectoine and hydroxyectoine inhibit aggregation and neurotoxicity of Alzheimer's beta-amyloid.
    Kanapathipillai M, Lentzen G, Sierks M, Park CB.
    FEBS Lett; 2005 Aug 29; 579(21):4775-80. PubMed ID: 16098972
    [Abstract] [Full Text] [Related]

  • 16. Zinc binding to amyloid-beta: isothermal titration calorimetry and Zn competition experiments with Zn sensors.
    Talmard C, Bouzan A, Faller P.
    Biochemistry; 2007 Nov 27; 46(47):13658-66. PubMed ID: 17983245
    [Abstract] [Full Text] [Related]

  • 17. Oxidative metabolites accelerate Alzheimer's amyloidogenesis by a two-step mechanism, eliminating the requirement for nucleation.
    Bieschke J, Zhang Q, Powers ET, Lerner RA, Kelly JW.
    Biochemistry; 2005 Apr 05; 44(13):4977-83. PubMed ID: 15794636
    [Abstract] [Full Text] [Related]

  • 18. Generation of reactive oxygen species by beta amyloid fibrils and oligomers involves different intra/extracellular pathways.
    Cenini G, Cecchi C, Pensalfini A, Bonini SA, Ferrari-Toninelli G, Liguri G, Memo M, Uberti D.
    Amino Acids; 2010 Apr 05; 38(4):1101-6. PubMed ID: 19582548
    [Abstract] [Full Text] [Related]

  • 19. The amyloid beta peptide (Abeta(1-40)) is thermodynamically soluble at physiological concentrations.
    Sengupta P, Garai K, Sahoo B, Shi Y, Callaway DJ, Maiti S.
    Biochemistry; 2003 Sep 09; 42(35):10506-13. PubMed ID: 12950178
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.